Remibrutinib, a Novel Bruton’s Tyrosine Kinase Inhibitor, Exhibits Improved Target Selectivity and Potency In Vitro (P8-3.003)
用户qgRSP4os3S6M
4天前
20
10
已关闭
DOI: 10.1212/wnl.0000000000203619
文献链接: https://www.neurology.org/doi/10.1212/WNL.0000000000203619
其他信息:
出版社: Ovid Technologies (Wolters Kluwer Health)
作者: Bernd Kieseier; Bruno Cenni; Robert Pulz; Daniela Angst; Denis Eichlisberger; Marina Ziehn

